# Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

> **NCT01270841** · PHASE2 · COMPLETED · sponsor: **Repros Therapeutics Inc.** · enrollment: 83 (actual)

## Conditions studied

- Secondary Hypogonadism

## Interventions

- **DRUG:** Placebo
- **DRUG:** topical testosterone
- **DRUG:** Androxal

## Key facts

- **NCT ID:** NCT01270841
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270841, "Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01270841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*